374 related articles for article (PubMed ID: 33633739)
41. Receptors for pro-resolving mediators are increased in Alzheimer's disease brain.
Emre C; Hjorth E; Bharani K; Carroll S; Granholm AC; Schultzberg M
Brain Pathol; 2020 May; 30(3):614-640. PubMed ID: 31912564
[TBL] [Abstract][Full Text] [Related]
42. Functional roles of sphingosine, sphingosine 1-phosphate, and methylsphingosines: in regard to membrane sphingolipid signaling pathways.
Igarashi Y
J Biochem; 1997 Dec; 122(6):1080-7. PubMed ID: 9498549
[TBL] [Abstract][Full Text] [Related]
43. Specialized Pro-Resolving Mediators from Omega-3 Fatty Acids Improve Amyloid-β Phagocytosis and Regulate Inflammation in Patients with Minor Cognitive Impairment.
Fiala M; Terrando N; Dalli J
J Alzheimers Dis; 2015; 48(2):293-301. PubMed ID: 26401996
[TBL] [Abstract][Full Text] [Related]
44. Sphingosine kinases, sphingosine-1-phosphate and sphingolipidomics.
Maceyka M; Milstien S; Spiegel S
Prostaglandins Other Lipid Mediat; 2005 Sep; 77(1-4):15-22. PubMed ID: 16099387
[TBL] [Abstract][Full Text] [Related]
45. Gene expression alterations in the sphingolipid metabolism pathways during progression of dementia and Alzheimer's disease: a shift toward ceramide accumulation at the earliest recognizable stages of Alzheimer's disease?
Katsel P; Li C; Haroutunian V
Neurochem Res; 2007; 32(4-5):845-56. PubMed ID: 17342407
[TBL] [Abstract][Full Text] [Related]
46. Drug Development for Alzheimer's Disease: Microglia Induced Neuroinflammation as a Target?
Dong Y; Li X; Cheng J; Hou L
Int J Mol Sci; 2019 Jan; 20(3):. PubMed ID: 30696107
[TBL] [Abstract][Full Text] [Related]
47. Impaired Resolution of Inflammation in Alzheimer's Disease: A Review.
Whittington RA; Planel E; Terrando N
Front Immunol; 2017; 8():1464. PubMed ID: 29163531
[TBL] [Abstract][Full Text] [Related]
48. ω-3 polyunsaturated fatty acids-derived lipid metabolites on angiogenesis, inflammation and cancer.
Wang W; Zhu J; Lyu F; Panigrahy D; Ferrara KW; Hammock B; Zhang G
Prostaglandins Other Lipid Mediat; 2014 Oct; 113-115():13-20. PubMed ID: 25019221
[TBL] [Abstract][Full Text] [Related]
49. Oxidation of polyunsaturated fatty acids to produce lipid mediators.
Christie WW; Harwood JL
Essays Biochem; 2020 Sep; 64(3):401-421. PubMed ID: 32618335
[TBL] [Abstract][Full Text] [Related]
50. Heart sphingolipids in health and disease.
Baranowski M; Górski J
Adv Exp Med Biol; 2011; 721():41-56. PubMed ID: 21910081
[TBL] [Abstract][Full Text] [Related]
51. Metabolism and biological functions of two phosphorylated sphingolipids, sphingosine 1-phosphate and ceramide 1-phosphate.
Kihara A; Mitsutake S; Mizutani Y; Igarashi Y
Prog Lipid Res; 2007 Mar; 46(2):126-44. PubMed ID: 17449104
[TBL] [Abstract][Full Text] [Related]
52. [Cyclooxygenases, lipoxygenases, their targeted drugs and the prevention of Alzheimer's disease].
Shen JN; Xu LX; Wang R
Yao Xue Xue Bao; 2013 Dec; 48(12):1743-54. PubMed ID: 24689230
[TBL] [Abstract][Full Text] [Related]
53. Endogenous conversion of omega-6 into omega-3 fatty acids improves neuropathology in an animal model of Alzheimer's disease.
Lebbadi M; Julien C; Phivilay A; Tremblay C; Emond V; Kang JX; Calon F
J Alzheimers Dis; 2011; 27(4):853-69. PubMed ID: 21914946
[TBL] [Abstract][Full Text] [Related]
54. Alzheimer's disease and inflammation: a review of cellular and therapeutic mechanisms.
Halliday G; Robinson SR; Shepherd C; Kril J
Clin Exp Pharmacol Physiol; 2000; 27(1-2):1-8. PubMed ID: 10696521
[TBL] [Abstract][Full Text] [Related]
55. Modulatory Effects of Fingolimod (FTY720) on the Expression of Sphingolipid Metabolism-Related Genes in an Animal Model of Alzheimer's Disease.
Jęśko H; Wencel PL; Lukiw WJ; Strosznajder RP
Mol Neurobiol; 2019 Jan; 56(1):174-185. PubMed ID: 29687345
[TBL] [Abstract][Full Text] [Related]
56. Aging, sex, metabolic and life experience factors: Contributions to neuro-inflammaging in Alzheimer's disease research.
Singhaarachchi PH; Antal P; Calon F; Culmsee C; Delpech JC; Feldotto M; Geertsema J; Hoeksema EE; Korosi A; Layé S; McQualter J; de Rooij SR; Rummel C; Slayo M; Sominsky L; Spencer SJ
Neurosci Biobehav Rev; 2024 Jul; 162():105724. PubMed ID: 38762130
[TBL] [Abstract][Full Text] [Related]
57. Neuroinflammatory responses in Alzheimer's disease.
Dansokho C; Heneka MT
J Neural Transm (Vienna); 2018 May; 125(5):771-779. PubMed ID: 29273951
[TBL] [Abstract][Full Text] [Related]
58. Specialized Pro-Resolving Lipid Mediators: Emerging Therapeutic Candidates for Multiple Sclerosis.
Zahoor I; Giri S
Clin Rev Allergy Immunol; 2021 Apr; 60(2):147-163. PubMed ID: 32495237
[TBL] [Abstract][Full Text] [Related]
59. Analysis of sphingosine 1-phosphate, ceramides, and other bioactive sphingolipids by high-performance liquid chromatography-tandem mass spectrometry.
Sullards MC; Merrill AH
Sci STKE; 2001 Jan; 2001(67):pl1. PubMed ID: 11752637
[TBL] [Abstract][Full Text] [Related]
60. Specialized Pro-Resolving Lipid Mediators: The Future of Chronic Pain Therapy?
Chávez-Castillo M; Ortega Á; Cudris-Torres L; Duran P; Rojas M; Manzano A; Garrido B; Salazar J; Silva A; Rojas-Gomez DM; De Sanctis JB; Bermúdez V
Int J Mol Sci; 2021 Sep; 22(19):. PubMed ID: 34638711
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
